This paper is only available as a PDF. To read, Please Download here.
One hundred patients with inducible ventricular tachycardia (VT) on electrophysiologic studies underwent serial drug testing with procainamide, lidocaine and lorcainide to determine comparative efficacy. Acute intravenous administration was followed by repeat programmed electrical stimulation (PES) studies on separate days for each antiarrhythmic agent. Lorcainide prevented VT induction in 69% of the 100 patients studied, procainamide in 50% of the 75 patients studied and lidocaine in 30% of 53 patients. After PES and serial drug testing, 46 patients were started on lorcainide, 9 on procainamide and 45 on other antiarrhythmic drug regimens. Eighty percent of the patients have remained on lorcainide therapy, whereas 47% have continued on other drug therapies started over 17.5-month mean follow-up period. Despite sleepwake disturbances and a need for sedation at night, lorcainide therapy was well tolerated in this population and remained an effective antiarrhythmic agent with prolonged administration.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Cardiology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Long term survival of patients with malignant ventricular arrhythmias treated with antiarrhythmic drugs.Am J Cardiol. 1982; 50: 437-443
- Clinical factors predicting successful etectrophysiologic pharmacologic study in patients with ventricular tachycardia.J Am Coll Cardiol. 1983; 1: 409-416
- Clinical characteristics and long-term follow-up in 119 survivors of cardiac arrest: relation to inducibility at electrophysiologic testing.Am J Cardiol. 1983; 52: 969-974
- Sustained ventricular tachycardia during the early post infarction period: electrophysiologic findings and prognosis for survival.J Am Coll Cardiol. 1983; 2: 240-250
- Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long term antiarrhythmic therapy.N Engl J Med. 1980; 303: 607-613
- Accuracy of the ventricular tachycardia induction study for predicting long term efficacy and inefficacy of antiarrhythmic drugs.N Engl J Med. 1980; 303: 1073-1077
- New antiarrhythmic drugs: their place in therapy.Drugs. 1981; 22: 363-400
- the efficacy and safety of lorcainide in the treatment of ventricular arrhythmias as assessed by frequent Holter monitoring.in: Diagnosis and pharmacotherapy of life threatening arrhythmias. 49. 1981: 149-151
- Pharmacokinetics of lorcainide, a new antiarrhythmic drug in patients with cardiac rhythm disorders.Am J Cardiol. 1981; 48: 157-163
- Lorcainide infusion in the treatment of ventricular premature beats (VPB).Eur J Clin Pharmacol. 1979; 16: 1-6
- Comparative electrophysiology of lorcainide and its major metabolite, nortorcainide, in the dog. (abstr).Circulation. 1981; 64: IV-127
- Lorcainide (R15889), a first review.Acta Cardiol. 1981; 36: 207-234
- The response to procalnamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.Circulation. 1983; 67: 30-37
- Electrophysiologic and antiarrhythmic effects of oral flecainide in patients with inducible ventricular tachycardia.J Am Coll Cardiol. 1983; 2: 105-114
- Electrophysiologic and hemodynamic studies in patients resuscitated from cardiac arrest. 1980; 46: 948-955
- Determinants of survival in patients with ventricular tachyarrhythmias.N Engl J Med. 1983; 308: 1436-1442
- Prevention of recurrent sudden cardiac arrest: role of provocation electropharmacologic testing.J Am Coll Cardiol. 1983; 2: 418-425
- Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.Circulation. 1978; 58: 986-987
- Incidence and clinical significance of induced ventricular tachycardia.Am J Cardiol. 1980; 45: 725-731
- Electrophysiologic studies in non-sustained ventricular tachycardia: relation to underlying heart disease.Am J Cardiol. 1983; 52: 985-991
- Use of non-sustained ventricular tachycardia as a guide to antiarrhythmic drug therapy in patients with malignant ventricular arrhythmias.Am Heart J. 1983; 105: 181-188
- Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.Circulation. 1982; 54: 886-893
- Sustained ventricular tachycardia in recent canine myocardial infarction.Circulation. 1980; 62: 980-987
- Electrophysiologic and anatomic correlations of sustained ventricular tachyarrhythmias in a model of chronic myocardial infarction.Am J Cardiol. 1980; 45: 583-590
- Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency.Circulation. 1978; 58: 408-414
☆This study was supported in part by Janssen Pharmaceutica, Inc. Dr. Somberg is an Established Investigator of the American Heart Association.
© 1984 Published by Elsevier Inc.